Healthcare

New opportunities in pancreatic cancer: RAS inhibitors, highly complex surgery and integrated care

Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), is taking part in the development of new RAS inhibitors, one of the most promising therapeutic strategies in pancreatic cancer, now also in the early stages of the disease. 

A patient referred from Mallorca receives a specialist second opinion at Hospital Clínic, one of Spain’s three national reference centres (CSUR, from the Spanish Centros, Servicios y Unidades de Referencia) for surgery of borderline resectable and locally advanced pancreatic cancer. 

To mark World Pancreatic Cancer Day, 4CB specialists call for a care model that brings all professionals together around the patient to ensure the best care and support, and highlight the importance of referral networks to specialised centres.

From left to right; Dra. Olga Morató, Dra. Elizabeth Pando, Sra. Magdalena Bennassar, Dra. Teresa Macarulla
Listen
Keep reading about: